You are here

Gilead Sciences' patent loss to Merck started with a broken friendship

Monday, December 19, 2016 - 05:50


IF Gilead Sciences Inc has to pay Merck & Co US$2.54 billion in patent royalties, it may come down to the details of what happened between two scientists who once were close friends.

Merck claims its Idenix unit, which it bought in 2014 for about US$3.85 billion,

Market voices on:

Pair your daily business read with the perfect cup of espresso.

Subscribe to The Business Times today to receive your very own Nespresso Inissia coffee machine worth $188.

Find out more at

Powered by GET.comGetCom